Anebulo Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Anebulo Pharmaceuticals

20/09/2023 21:55

* Anebulo Pharmaceuticals Inc  ANEB.OQ  reported a quarterly
adjusted loss of 10 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 11 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Anebulo Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 10 cents​.
    * The mean earnings estimate of analysts had risen by
about 4.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Anebulo Pharmaceuticals Inc shares had risen by 48.5% this
quarter and gained 44.0% so far this year.
    * The company reported a quarterly loss of $2.5 million.
    * Wall Street's median 12-month price target for Anebulo
Pharmaceuticals Inc is $7.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
September 20 at 08:54 p.m. UTC. ​All figures in US dollars
unless otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.11          -0.10          Beat
 Mar. 31 2023      -0.16          -0.11          Beat
 Dec. 31 2022      -0.11          -0.15          Missed
 Sep. 30 2022      -0.10          -0.11          Missed